A Form 4 filed with the SEC on September 18, 2026, discloses that Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp. /DE (NASDAQ:CLOV), sold 1,921 shares of Class A Common Stock on September 17, 2026, under a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Jamie L. Reynoso, identified in the filing as CEO, Medicare Advantage at Clover Health Investments, Corp. /DE
  • Shares sold: 1,921 shares of Class A Common Stock disposed of (transaction code S) on September 17, 2026
  • Sale price: $4.56 per share, as stated in the filing
  • Remaining ownership: 2,803,446 shares of Class A Common Stock held directly following the transaction
  • 10b5-1 plan: The sale was made pursuant to a Rule 10b5-1 trading plan adopted by Reynoso on March 12, 2026
  • Filing form: Signed by Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso on September 18, 2026

Clover Health Officer Reports Share Sale Under Pre-Scheduled Trading Plan

According to the Form 4 filed on September 18, 2026, Jamie L. Reynoso, who serves as CEO of Medicare Advantage at Clover Health Investments, Corp. /DE, disposed of 1,921 shares of Class A Common Stock at a price of $4.56 per share. The transaction took place on September 17, 2026, and is recorded as a sale (transaction code S) in Table I of the filing, reflecting a direct ownership position.

The filing discloses that the transaction was executed under a Rule 10b5-1 trading plan, which Reynoso adopted on March 12, 2026. Clover Health Investments, Corp. /DE operates in the Medicare Advantage sector, providing health insurance plans under that government program. Following the reported sale, Reynoso's direct beneficial ownership in NASDAQ:CLOV Class A Common Stock stands at 2,803,446 shares, as stated in the filing. No derivative securities transactions were reported in Table II of this Form 4.

The Form 4 was filed by one reporting person and was signed by Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso. The filing also notes that a box was checked indicating the transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), consistent with the explanation provided in the footnote to Table I.

What Was Disclosed

This Form 4 reports the September 17, 2026, sale of 1,921 shares of Clover Health Investments Class A Common Stock at $4.56 per share by officer Jamie L. Reynoso, executed under a Rule 10b5-1 plan adopted March 12, 2026, leaving Reynoso with 2,803,446 shares held directly.